The moment for AI in healthcare

The convergence of artificial intelligence and healthcare is no longer a promise, but a central component of day-to-day operations across hospitals, insurers, laboratories, and biotechnology companies. In a landscape defined by administrative overload, clinician burnout, fragmented data, and regulatory pressure, generative AI is emerging as a key enabler for scaling efficiency without compromising quality.

Within this transformation, Large Language Models (LLMs) have rapidly evolved from simple conversational interfaces into specialized copilots systems capable of embedding themselves into clinical, administrative, and scientific workflows. Their real impact, however, materializes only when they operate under robust security controls, traceability, and regulatory compliance.

In this article, we explore three major families of solutions shaping the agenda:

• ChatGPT Health and OpenAI for Healthcare
• Claude for Healthcare and Claude for Life Sciences (Anthropic)
• Biomolecular and scientific AI platforms such as NVIDIA BioNeMo

Our focus is on what these technologies are, how they are used, where they create real value, and how organizations can integrate them strategically.

Technology overview

ChatGPT Health (OpenAI): AI centered on users and health understanding

OpenAI introduced ChatGPT Health as a dedicated experience within ChatGPT, designed to help individuals better understand their health information by connecting medical records and wellness applications (such as Apple Health or MyFitnessPal) within an environment featuring enhanced privacy protections. This space:

• Keeps health conversations isolated from the rest of ChatGPT usage.
• Does not use health data to train models.
• Is not intended for medical diagnosis or treatment.
• Has initially limited access, with certain features depending on regional availability and specific integrations (e.g., Apple Health on iOS)

From an adoption standpoint, ChatGPT Health is primarily oriented toward end users (B2C) and initiatives focused on patient engagement and health literacy, rather than deep integration into regulated corporate healthcare systems.

OpenAI for Healthcare: generative AI for healthcare organizations

In parallel, OpenAI launched OpenAI for Healthcare, an offering specifically designed for hospitals, insurers, clinics, and healthcare organizations, with a strong focus on security, compliance, and scalability. This offering includes:

• ChatGPT for Healthcare (an enterprise environment)
• API access to embed AI directly into products and internal workflows
• The possibility to apply for a Business Associate Agreement (BAA) to support HIPAA compliance in the U.S. (HIPAA is the primary federal law governing the privacy and security of protected health information in the United States).

Key use cases include:

• Clinical documentation generation and summarization
• Drafting medical notes and referral letters
• Patient education in easy language
• Support for administrative and operational workflows

Unlike ChatGPT Health, this offering is explicitly designed for enterprise integration, incorporating controls such as auditing, identity management, and secure deployment models.

In enterprise healthcare environments, AI systems are expected not only to generate text, but to triangulate information across structured records, clinical guidelines, coding systems, and external knowledge bases. This ability to ground responses in multiple validated sources reduces hallucination risk and aligns outputs with regulatory and operational standards.

Claude for Healthcare and for Life Sciences (Anthropic)

Anthropic has taken a complementary approach, launching healthcare-specific products under the Claude brand, with a strong emphasis on real-world workflows.

Claude for Healthcare

Claude for Healthcare primarily targets providers and payers, addressing one of the system’s largest pain points: administrative burden. The product includes grounding and connectors to key sources such as: CMS Coverage Database, ICD-10, NPI Registry, PubMed

This enables use cases including:

• Prior authorization automation
• Coverage and eligibility review
• Medical coding support
• Drafting appeals and claims
• Contextual access to clinical evidence

👉 Official announcement: https://www.anthropic.com/news/healthcare-life-sciences

Claude for Life Sciences

Claude for Life Sciences is oriented toward biotechnology and pharmaceutical organizations, with a focus on scientific research and operational support. Use cases include:

• Scientific literature review and synthesis
• Clinical trial design and documentation support
• Assisted generation of regulatory reports
• Internal assistants for R&D teams

Anthropic has also announced research credit programs, reinforcing its positioning as a scientific research copilot.

Comparison: strategic positioning

Use cases, applications, and opportunities

Reducing administrative burden

Automating authorizations, claims, and medical coding represents one of the clearest quick wins for generative AI in healthcare. Solutions like Claude for Healthcare help reduce processing time, errors, and friction between system actors.

Improving the patient experience

Tools such as ChatGPT Health and OpenAI’s enterprise healthcare solutions enable:

• Clear explanations of tests and diagnoses
• Better preparation for medical appointments
• Ongoing patient education

This directly impacts treatment adherence and patient satisfaction.

Accelerating biotechnology research

In scientific environments, Claude for Life Sciences and biomolecular AI platforms help:

• Dramatically reduce literature review time
• Assist in protocol generation
• Improve research team productivity

This value often emerges through retrieval-augmented generation (RAG) pipelines grounded in regulated and peer-reviewed sources such as PubMed, clinical guidelines, ICD-10 classifications, or regulatory frameworks (FDA, EMA). By anchoring model outputs to validated scientific repositories, organizations can reduce hallucination risk while preserving traceability and compliance.

For example, a research copilot may retrieve and synthesize peer-reviewed articles from PubMed, cross-reference disease classifications under ICD-10, and align outputs with regulatory guidance before generating protocol drafts. This triangulation across structured and validated sources is essential in high-stakes scientific environments.

Future outlook: AI across the entire healthcare lifecycle

The natural evolution of these technologies points toward an ecosystem where AI:

• Supports clinical and administrative decision-making
• Reduces operational friction
• Accelerates scientific research
• Improves patient experience
• Preserves traceability and regulatory compliance

This is not about replacing professionals, but about augmenting their decision-making capacity through contextual, synthesized, and reliable information.

Conclusion

Generative AI in healthcare is no longer experimental. Solutions such as ChatGPT Health, OpenAI for Healthcare, and Claude for Healthcare / Life Sciences are already demonstrating tangible value when integrated with the right governance, strategy, and business focus.

For healthcare and biotechnology organizations, the challenge is no longer whether to adopt AI, but how to do so responsibly, securely, and in alignment with strategic objectives.

At Marvik, we support our clients along this journey—, from technology exploration to the production-ready, measurable deployment of AI solutions in healthcare and life sciences.